Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal

Ruihua Liu1, Yuan Peng1, Haishan Wu1

  • 1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, 510080, China.

Insights

An elevated uric acid to high-density lipoprotein cholesterol ratio (UHR) predicts higher risks of death in peritoneal dialysis (PD) patients. This finding highlights UHR as a potential marker for cardiovascular mortality in PD populations.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Serum uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) are established cardiovascular mortality risk factors.
  • The UA to HDL-C ratio (UHR) has shown predictive value in diabetes but remains unstudied in peritoneal dialysis (PD) patients.

Purpose of the Study:

  • To investigate the association between the UA to HDL-C ratio (UHR) and cardiovascular (CV) mortality in patients undergoing peritoneal dialysis (PD).

Main Methods:

  • A retrospective cohort study included 1953 incident PD patients followed for a median of 61.3 months.
  • Patients were stratified into quartiles based on baseline UHR.
  • Multivariate Cox regression analysis was used to assess the association between UHR and mortality outcomes.

Main Results:

  • The mean baseline UHR was 16.4 ± 6.7%.
  • Elevated UHR, particularly the highest quartile, was significantly associated with increased all-cause (HR 1.35) and CV mortality (HR 1.46) compared to the second quartile.
  • Subgroup analyses indicated a stronger association in elderly PD patients (≥65 years), those with malnutrition, diabetes, or a history of cardiovascular disease.

Conclusions:

  • An elevated UHR is a significant predictor of increased all-cause and cardiovascular mortality in peritoneal dialysis patients.
  • UHR may serve as a valuable prognostic marker for cardiovascular risk stratification in this vulnerable population.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
81
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
285
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
92
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
284
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
79
Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
2.1K